Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Stackpole"'
Autor:
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, Sietse Q Nagelkerke, Khiyam Hussain, Rosalind Ganderton, Charlotte Lee, Lee R Machado, Edward J Hollox, Helen Parker, Kate V Latham, Taco W Kuijpers, Kathleen N Potter, Sarah E Coupland, Andrew Davies, Michael Stackpole, Melanie Oates, Andrew R Pettitt, Martin J Glennie, Mark S Cragg, Jonathan C Strefford
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0145040 (2016)
Externí odkaz:
https://doaj.org/article/7e21e6e38b634c45a1e1cc98a60d0463
Autor:
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, Sietse Q Nagelkerke, Khiyam Hussain, Rosalind Ganderton, Charlotte Lee, Lee R Machado, Edward J Hollox, Helen Parker, Kate V Latham, Taco W Kuijpers, Kathleen N Potter, Sarah E Coupland, Andrew Davies, Michael Stackpole, Melanie Oates, Andrew R Pettitt, Martin J Glennie, Mark S Cragg, Jonathan C Strefford
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142379 (2015)
Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (FcγRs). The low-affinity FcγR genes are highly homologous, map to a complex locus at 1p23 and harbo
Externí odkaz:
https://doaj.org/article/4a1b6632f06b4ec68c7251299395cd8e
Autor:
Michael Stackpole
Capturing the electric short fiction energy that led Robert E. Howard to be one of the top fantasy writers of the century, with exclusive serialized eBook stories starring Conan, Solomon Kane, and more by many of today's top writers in fantasy and sw
Autor:
Michael Stackpole, Charlotte E. Lee, Helen L. Parker, Sietse Q. Nagelkerke, Matthew J. J. Rose-Zerilli, Chantal E. Hargreaves, Taco W. Kuijpers, Jonathan C. Strefford, Andrew R. Pettitt, Chisako Iriyama, Melanie Oates, Rosalind Ganderton, Lee Machado, Sarah E. Coupland, Kate V. Latham, Andrew Davies, Mark S. Cragg, Khiyam Hussain, Kathleen N. Potter, Edward J. Hollox, Martin J. Glennie
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0145040 (2016)
Fig 4 is incorrect. The figure is an older version, which contains an inaccurate summary of data. The authors have provided a corrected version here. Fig 4 Performance of FcγR -targeted probes in healthy donors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edeaa1ed69c97f9504279b8d042ad9ac
https://doaj.org/article/7e21e6e38b634c45a1e1cc98a60d0463
https://doaj.org/article/7e21e6e38b634c45a1e1cc98a60d0463
Autor:
Andrew R. Pettitt, Sarah E. Coupland, Rosalind Ganderton, Mark S. Cragg, Khiyam Hussain, Michael Stackpole, Matthew Jj Rose-Zerilli, Kathleen N. Potter, Melanie Oates, Edward J. Hollox, Jonathan C. Strefford, Chantal E. Hargreaves, Lee Machado, Charlotte E. Lee, Chisako Iriyama
Publikováno v:
Blood. 124:2996-2996
Development of the anti-CD20 antibody, rituximab, heralded the start of monoclonal antibody (mAb) therapy as an effective means of treating cancer. Despite its undoubted impact, clinical responses remain variable and cures are rarely achieved. Eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a95906e8ab9cd4197de38fddeb69aad8
https://doi.org/10.1182/blood.v124.21.2996.2996
https://doi.org/10.1182/blood.v124.21.2996.2996